Long-term safety and efficacy of tofogliflozin add-on to insulin in patients with type 2 diabetes: results from a 52-week, multicenter, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS).
about
Long-term safety and efficacy of tofogliflozin add-on to insulin in patients with type 2 diabetes: results from a 52-week, multicenter, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@en
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@nl
type
label
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@en
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@nl
prefLabel
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@en
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@nl
P2093
P2860
P356
P1476
Long-term safety and efficacy ...... 4 study in Japan (J-STEP/INS).
@en
P2093
Masahiro Tamura
Masayuki Senda
Ryoji Gunji
Yasuo Terauchi
P2860
P304
P356
10.1111/DOM.13213
P50
P577
2018-02-11T00:00:00Z